Topic: Deena Beasley
LOS ANGELES (Reuters) - A small, mid-stage trial of an experimental breast cancer drug developed by Peregrine Pharmaceuticals Inc showed that 74 percent of patients responded to the treatment, according to the company.The Phase 2 trial enrolled 46 patients with advanced breast ...
NEW YORK (Reuters) - A closely watched experimental hepatitis C treatment being developed by Vertex Pharmaceuticals Inc led to a 75 percent cure rate in a pivotal late-stage trial of previously untreated patients, the company said on Tuesday.The results from the first ...
LOS ANGELES (Reuters) - Low-budget fright film " "Paranormal" went into wider release by Paramount after playing to sellout crowds at midnight-only screenings over the past few weekends in a handful of markets determined by online balloting.Taking a page from the playbook of ...
